sanofi-aventis Pakistan Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was PKR 4,521.4 million compared to PKR 3,849.2 million a year ago. Net income was PKR 24.16 million compared to net loss of PKR 94.61 million a year ago. Basic earnings per share from continuing operations was PKR 2.5 compared to basic loss per share from continuing operations of PKR 9.81 a year ago.
For the nine months, sales was PKR 14,045.25 million compared to PKR 11,919.82 million a year ago. Net income was PKR 213.01 million compared to PKR 349.22 million a year ago. Basic earnings per share from continuing operations was PKR 22.09 compared to PKR 36.21 a year ago.